Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The transmembrane region is responsible for targeting of adaptor protein LAX into "heavy rafts"

M. Hrdinka, P. Otahal, V. Horejsi,

. 2012 ; 7 (5) : e36330.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: The importance of membrane compartmentalization into specific membrane microdomains has been shown in many biological processes such as immunoreceptor signaling, membrane trafficking, pathogen infection, and tumor progression. Microdomains like lipid rafts, caveolae and tetraspanin enriched microdomains are relatively resistant to solubilization by some detergents. Large detergent-resistant membrane fragments (DRMs) resulting from such membrane solubilization can be conveniently isolated by density gradient ultracentrifugation or gel filtration. Recently, we described a novel type of raft-like membrane microdomains producing, upon detergent Brij98 solubilization, "heavy DRMs" and containing a number of functionally relevant proteins. Transmembrane adaptor protein LAX is a typical "heavy raft" protein. The present study was designed to identify the molecular determinants targeting LAX-derived constructs to heavy rafts. METHODOLOGY/PRINCIPAL FINDINGS: We prepared several constructs encoding chimeric proteins containing various informative segments of the LAX sequence and evaluated their effects on targeting to heavy rafts. Replacement of the polybasic membrane-proximal part of LAX by CD3ε-derived membrane-proximal part had no effect on LAX solubilization. Similarly, the membrane-proximal part of LAX, when introduced into non-raft protein CD25 did not change CD25 detergent solubility. These results indicated that membrane-proximal part of LAX is not important for LAX targeting to heavy rafts. On the other hand, the replacement of transmembrane part of CD25 by the transmembrane part of LAX resulted in targeting into heavy rafts. We also show that LAX is not S-acylated, thus palmitoylation is not involved in LAX targeting to heavy rafts. Also, covalent dimerization was excluded as a cause of targeting into heavy rafts. CONCLUSIONS/SIGNIFICANCE: We identified the transmembrane domain of LAX as a first motif targeting transmembrane protein constructs to detergent-resistant heavy rafts, a novel type of membrane microdomains containing a number of physiologically important proteins.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13000755
003      
CZ-PrNML
005      
20130108115840.0
007      
ta
008      
130108s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0036330 $2 doi
035    __
$a (PubMed)22662118
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hrdinka, Matous $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
245    14
$a The transmembrane region is responsible for targeting of adaptor protein LAX into "heavy rafts" / $c M. Hrdinka, P. Otahal, V. Horejsi,
520    9_
$a BACKGROUND: The importance of membrane compartmentalization into specific membrane microdomains has been shown in many biological processes such as immunoreceptor signaling, membrane trafficking, pathogen infection, and tumor progression. Microdomains like lipid rafts, caveolae and tetraspanin enriched microdomains are relatively resistant to solubilization by some detergents. Large detergent-resistant membrane fragments (DRMs) resulting from such membrane solubilization can be conveniently isolated by density gradient ultracentrifugation or gel filtration. Recently, we described a novel type of raft-like membrane microdomains producing, upon detergent Brij98 solubilization, "heavy DRMs" and containing a number of functionally relevant proteins. Transmembrane adaptor protein LAX is a typical "heavy raft" protein. The present study was designed to identify the molecular determinants targeting LAX-derived constructs to heavy rafts. METHODOLOGY/PRINCIPAL FINDINGS: We prepared several constructs encoding chimeric proteins containing various informative segments of the LAX sequence and evaluated their effects on targeting to heavy rafts. Replacement of the polybasic membrane-proximal part of LAX by CD3ε-derived membrane-proximal part had no effect on LAX solubilization. Similarly, the membrane-proximal part of LAX, when introduced into non-raft protein CD25 did not change CD25 detergent solubility. These results indicated that membrane-proximal part of LAX is not important for LAX targeting to heavy rafts. On the other hand, the replacement of transmembrane part of CD25 by the transmembrane part of LAX resulted in targeting into heavy rafts. We also show that LAX is not S-acylated, thus palmitoylation is not involved in LAX targeting to heavy rafts. Also, covalent dimerization was excluded as a cause of targeting into heavy rafts. CONCLUSIONS/SIGNIFICANCE: We identified the transmembrane domain of LAX as a first motif targeting transmembrane protein constructs to detergent-resistant heavy rafts, a novel type of membrane microdomains containing a number of physiologically important proteins.
650    _2
$a adaptorové proteiny vezikulární transportní $x chemie $x genetika $x metabolismus $7 D033942
650    _2
$a buněčné linie $7 D002460
650    _2
$a lidé $7 D006801
650    _2
$a membránové mikrodomény $x genetika $x metabolismus $7 D021962
650    _2
$a interakční proteinové domény a motivy $7 D054730
650    _2
$a multimerizace proteinu $7 D055503
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Otahal, Pavel
700    1_
$a Horejsi, Vaclav
773    0_
$w MED00180950 $t PLoS ONE $x 1932-6203 $g Roč. 7, č. 5 (2012), s. e36330
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22662118 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130108 $b ABA008
991    __
$a 20130108114439 $b ABA008
999    __
$a ok $b bmc $g 963537 $s 798919
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 7 $c 5 $d e36330 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20130108

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...